NASDAQ: LTGOLatigo Biotherapeutics Inc Stock Ownership - Who owns Latigo Biotherapeutics?
Insider buying vs selling
Have Latigo Biotherapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Foresite Capital Management V LLC | 10% Owner | 2026-08-10 | 140,000 | $18.00 | $2.52MBuy |
| James B. Tananbaum | Director | 2026-08-10 | 140,000 | $18.00 | $2.52MBuy |
LTGO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LTGO insiders and whales buy or sell their stock.
LTGO Shareholders
What type of owners hold Latigo Biotherapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Foresite Capital Management V LLC | 5.68% | 3,414,544 | $63.37M | Insider |
| James B. Tananbaum | 5.68% | 3,414,544 | $63.37M | Insider |
| Westlake Biopartners Fund I LP | 3.48% | 2,094,813 | $38.88M | Insider |
| Beth C. Seidenberg | 3.48% | 2,094,813 | $38.88M | Insider |
| Nima Farzan | 0.19% | 114,453 | $2.12M | Insider |
Latigo Biotherapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.